Related Experiment Video
Updated: Jun 13, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
MRI Assessment of Nigrosome in Parkinson's Disease: Is it Currently a Valuable Tool in Clinical Practice?
Agustina Ruiz Yanzi1,2,3, José Á Pineda-Pardo1,2, Elena Natera-Villalba1,2,4
1Centro Integral de Neurociencias AC (CINAC), HM Universitario Puerta del Sur, Madrid, Spain.
Background:
Dopaminergic neuron loss in the substantia nigra, particularly the nigrosomes, characterizes Parkinson's disease (PD). Nigrosome-1 absence on MRI has emerged as a potential PD biomarker.
Objectives:
Assess the diagnostic accuracy of nigrosome-1 detection for differentiating PD from essential tremor (ET) in clinical practice.
Methods:
Movement disorder neurologists without nigrosome evaluation experience, randomized into receiving or not training, assessed 3 Tesla MRIs from PD and ET patients. PD was defined by absence of at least one nigrosome. Diagnostic accuracy measures and inter-rater agreement were calculated.
Results:
Seventy-two MRIs were included (43 PD, 29 ET). Mean sensitivity, specificity, and accuracy were 78.2% (95% confidence interval: 71.2-85.3), 56.7% (50.0-64.0), 69.5% (65.3-73.9), without significant differences between groups. Specificity (P = 0.002) and accuracy (P = 0.029) increased with rating experience.
Conclusions:
Nigrosome assessment in routine MRI by inexperienced raters showed limited diagnostic performance, yet may improve with optimized protocols and continued practice.
More Related Videos
06:09Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
Neural Regulation
Applications Of NMR In Biology
The...
Magnetic Resonance Imaging
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology